Lai Wang, Global Head of R&D at BeiGene, Ltd. (BGNE), sold 1,312 shares at $354.26 ($465K) on 2021-06-07, disclosed to the SEC on 2021-06-09.
Open-market sale of $465k BGNE by Global Head of R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $354.26 | 656 | $232K | 50.0% |
| 2 | $354.26 | 656 | $232K | 50.0% |
| Total | $354.26 avg | 1,312 | $465K | 100% |
| Filing → |
| ONC | SELL | 2026-06-15 | $197K | — | Filing → |
| ONC | SELL | 2026-06-10 | $368K | — | Filing → |
| ONC | SELL | 2025-09-11 | $1.8M | — | Filing → |